1. Home
  2. Live Updates
  3. Dermata to Begin Enrolling Patients in DMT310 Phase 3 Acne C

Dermata to Begin Enrolling Patients in DMT310 Phase 3 Acne C

Dermata to Begin Enrolling Patients in DMT310 Phase 3 Acne Clinical Program in December 2023 based on Agreement with FDA on the Phase 3 Protocols

Dermata to Begin Enrolling Patients in DMT310 Phase 3 Acne Clinical Program in December 2023 based on Agreement with FDA on the Phase 3 Protocols

bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , San Diego , California , America , Gerry Proehl , Sean Proehl , Nasdaq , Dermata Therapeutics Inc , Exchange Commission , Spongilla Treatment Of Acne Research , Business Development , Drug Administration , Spongilla Treatment , Acne Research , Dermata Therapeutics , Chief Executive , Investigator Global Assessment , Private Securities Litigation Reform Act ,